|
Market Closed -
Nasdaq
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 14.95 USD | -2.48% |
|
-2.29% | -17.68% |
| 09-20 | Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to S&P Global BMI Index | CI |
| 08-19 | Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVALO THERAPEUTICS, INC. | Bio Therapeutic Drugs | -2.48% | -2.29% | -17.68% | +17.62% | -99.76% | 822M |  |  | |
- Stock Market
- Stocks
- AVTX Stock
- Charts Avalo Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
